APTAMER GROUP LTD LS-001
Aptamer Group PLC, together with its subsidiaries, provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers; and Optimer +, a platform that discovers and develops of hybrid DNA-protein molecules that … Read more
Market Cap & Net Worth: APTAMER GROUP LTD LS-001 (P0J)
APTAMER GROUP LTD LS-001 (F:P0J) has a market capitalization of $19.38 Million (€18.88 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #28375 globally and #3105 in its home market, demonstrating a -12.50% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying APTAMER GROUP LTD LS-001's stock price €0.01 by its total outstanding shares 2696978377 (2.70 Billion).
APTAMER GROUP LTD LS-001 Market Cap History: 2022 to 2026
APTAMER GROUP LTD LS-001's market capitalization history from 2022 to 2026. Data shows change from $1.52 Billion to $19.38 Million (-71.65% CAGR).
APTAMER GROUP LTD LS-001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how APTAMER GROUP LTD LS-001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of P0J by Market Capitalization
Companies near APTAMER GROUP LTD LS-001 in the global market cap rankings as of March 19, 2026.
Key companies related to APTAMER GROUP LTD LS-001 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
APTAMER GROUP LTD LS-001 Historical Marketcap From 2022 to 2026
Between 2022 and today, APTAMER GROUP LTD LS-001's market cap moved from $1.52 Billion to $ 19.38 Million, with a yearly change of -71.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €19.38 Million | -30.00% |
| 2025 | €27.68 Million | +400.00% |
| 2024 | €5.54 Million | -66.67% |
| 2023 | €16.61 Million | -98.91% |
| 2022 | €1.52 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of APTAMER GROUP LTD LS-001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $19.38 Million USD |
| MoneyControl | $19.38 Million USD |
| MarketWatch | $19.38 Million USD |
| marketcap.company | $19.38 Million USD |
| Reuters | $19.38 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.